P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- DOI
- 10.1097/01.hs9.0000969608.50678.3a
- Published
- 8
- Container
- HemaSphere
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/01.hs9.0000969608.50678.3a,
title = {P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA},
author = {Erica Brivio and Edoardo Pennesi and Marieke Willemse and Yilin Jiang and Vincent van der Velden and Berna Beverloo and Chad Hudson and Luke Kuttschreuter and Inge van der Sluis and Benoît Brethon and Francisco Bautista and Michael J. Burke and Nyla Heerema and Andrew Bukowinski and Stacy Cooper and Jessica Pollard and Ramamoorthy Nagasubramani and Michele Redell and Jean-Pierre Bourquin and Ray Pais and Jamie Frediani and Sandeep Batra and Nicoletta Bertorello and Jessica Boklan and Albert Kheradpour and Wade Kyono and Karey Kowalski and Benjamin Mizukawa and Donna Lancaster and Laura Murillo-Sanjuán and Julie Krystal and Yves Bertrand and Alwin Huitema and Harm van Tinteren and Franco Locatelli and Michael Roth and Nobuko Hijiya and Michel Zwaan},
year = {2023},
journal = {HemaSphere},
doi = {10.1097/01.hs9.0000969608.50678.3a},
url = {https://doi.org/10.1097/01.hs9.0000969608.50678.3a}
}RIS
TY - JOUR TI - P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA AU - Erica Brivio AU - Edoardo Pennesi AU - Marieke Willemse AU - Yilin Jiang AU - Vincent van der Velden AU - Berna Beverloo AU - Chad Hudson AU - Luke Kuttschreuter AU - Inge van der Sluis AU - Benoît Brethon AU - Francisco Bautista AU - Michael J. Burke AU - Nyla Heerema AU - Andrew Bukowinski AU - Stacy Cooper AU - Jessica Pollard AU - Ramamoorthy Nagasubramani AU - Michele Redell AU - Jean-Pierre Bourquin AU - Ray Pais AU - Jamie Frediani AU - Sandeep Batra AU - Nicoletta Bertorello AU - Jessica Boklan AU - Albert Kheradpour AU - Wade Kyono AU - Karey Kowalski AU - Benjamin Mizukawa AU - Donna Lancaster AU - Laura Murillo-Sanjuán AU - Julie Krystal AU - Yves Bertrand AU - Alwin Huitema AU - Harm van Tinteren AU - Franco Locatelli AU - Michael Roth AU - Nobuko Hijiya AU - Michel Zwaan PY - 2023 JO - HemaSphere DO - 10.1097/01.hs9.0000969608.50678.3a UR - https://doi.org/10.1097/01.hs9.0000969608.50678.3a ER -
APA
Brivio, E., Pennesi, E., Willemse, M., Jiang, Y., Velden, V. V. D., Beverloo, B., Hudson, C., Kuttschreuter, L., Sluis, I. V. D., Brethon, B., Bautista, F., Burke, M. J., Heerema, N., Bukowinski, A., Cooper, S., Pollard, J., Nagasubramani, R., Redell, M., Bourquin, J., Pais, R., Frediani, J., Batra, S., Bertorello, N., Boklan, J., Kheradpour, A., Kyono, W., Kowalski, K., Mizukawa, B., Lancaster, D., Murillo-Sanjuán, L., Krystal, J., Bertrand, Y., Huitema, A., Tinteren, H. V., Locatelli, F., Roth, M., Hijiya, N., & Zwaan, M. (2023). P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA. HemaSphere. https://doi.org/10.1097/01.hs9.0000969608.50678.3a
Source records
- doaj · retrieved 2026-09-26T10:43:35.576Z